Sorrento Therapeutics Company Profile (NASDAQ:SRNE)

About Sorrento Therapeutics

Sorrento Therapeutics logoSorrento Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in the discovery, acquisition, development and commercialization of drug therapeutics. Its primary therapeutic focus is oncology, including the treatment of chronic cancer pain. It is also developing therapeutic products for other indications, including immunology and infectious diseases. Its products in the pipeline include Chimeric Antigen Receptor-T Cell (CAR-T) programs, resiniferatoxin (RTX), and biosimilar/biobetter antibodies clinical development programs. Its pipeline also includes preclinical fully human therapeutic monoclonal antibodies (mAbs), including biosimilars/biobetters, fully human anti-PD-L1 and anti-PD-1 checkpoint inhibitors derived from its G-MAB library platform, antibody drug conjugates (ADCs), bispecific antibodies (BsAbs), as well as CAR-T and Chimeric Antigen Receptor Natural Killer (NK) cells (CAR. NK) for adoptive cellular immunotherapy.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: SRNE
  • CUSIP:
Key Metrics:
  • Previous Close: $6.53
  • 50 Day Moving Average: $6.49
  • 200 Day Moving Average: $6.21
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -11.46
  • P/E Growth: 0.00
  • Market Cap: $375.93M
  • Outstanding Shares: 57,570,000
  • Beta: 1.61
Additional Links:
Companies Related to Sorrento Therapeutics:

Analyst Ratings

Consensus Ratings for Sorrento Therapeutics (NASDAQ:SRNE) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $26.50 (305.82% upside)

Analysts' Ratings History for Sorrento Therapeutics (NASDAQ:SRNE)
Show:
DateFirmActionRatingPrice TargetDetails
8/12/2016Brean CapitalReiterated RatingBuyView Rating Details
8/4/2016FBR & CoReiterated RatingBuyView Rating Details
7/17/2016Rodman & RenshawReiterated RatingBuyView Rating Details
12/7/2015HC WainwrightInitiated CoverageBuy$45.00View Rating Details
8/3/2015MLV & Co.Initiated CoverageBuy$34.00View Rating Details
12/15/2014AegisReiterated RatingBuyView Rating Details
(Data available from 8/30/2014 forward)

Earnings

Earnings History for Sorrento Therapeutics (NASDAQ:SRNE)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/16/2015Q315($0.03)$1.28 million$1.10 millionViewN/AView Earnings Details
11/4/2014Q314($0.32)($0.27)$1.28 millionViewN/AView Earnings Details
8/18/2014($0.34)($0.33)ViewN/AView Earnings Details
5/23/2014($0.29)($0.44)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Sorrento Therapeutics (NASDAQ:SRNE)
Current Year EPS Consensus Estimate: $-1.44 EPS
Next Year EPS Consensus Estimate: $-0.57 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.52)($0.37)($0.45)
Q2 20161($0.15)($0.15)($0.15)
Q3 20161($0.15)($0.15)($0.15)
Q4 20161($0.15)($0.15)($0.15)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Sorrento Therapeutics (NASDAQ:SRNE)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Sorrento Therapeutics (NASDAQ:SRNE)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/29/2016Patrick Soon-ShiongMajor ShareholderSell3,400$5.82$19,788.00View SEC Filing  
6/23/2016Patrick Soon-ShiongMajor ShareholderSell6,901$5.85$40,370.85View SEC Filing  
6/15/2016Patrick Soon-ShiongMajor ShareholderSell19,836$5.87$116,437.32View SEC Filing  
6/14/2016Patrick Soon-ShiongMajor ShareholderSell53,764$6.14$330,110.96View SEC Filing  
6/13/2016Patrick Soon-ShiongMajor ShareholderSell37,792$6.15$232,420.80View SEC Filing  
3/7/2016Patrick Soon-ShiongMajor ShareholderSell100,000$6.19$619,000.00View SEC Filing  
8/26/2015Henry JiCEOBuy500$0.95$475.00View SEC Filing  
8/24/2015Henry JiCEOBuy8,888$12.84$114,121.92View SEC Filing  
8/21/2015Henry JiCEOBuy8,888$13.08$116,255.04View SEC Filing  
11/10/2014Henry JiCEOBuy5,999$4.83$28,975.17View SEC Filing  
11/7/2014Henry JiCEOBuy4,000$4.56$18,240.00View SEC Filing  
11/6/2014Henry JiCEOBuy3,000$4.53$13,590.00View SEC Filing  
12/5/2013Henry JiCEOBuy1,000$8.92$8,920.00View SEC Filing  
12/4/2013Henry JiCEOBuy1,000$8.54$8,540.00View SEC Filing  
11/25/2013Jaisim ShahDirectorBuy1,000$8.65$8,650.00View SEC Filing  
11/22/2013Henry JiCEOBuy1,000$8.47$8,470.00View SEC Filing  
11/22/2013Opko Health, Inc.Major ShareholderSell8,471$8.50$72,003.50View SEC Filing  
11/21/2013George UyInsiderBuy3,000$8.36$25,080.00View SEC Filing  
11/21/2013Opko Health, Inc.Major ShareholderSell4,269$8.53$36,414.57View SEC Filing  
11/20/2013Opko Health, Inc.Major ShareholderSell17,062$8.75$149,292.50View SEC Filing  
11/19/2013George UyInsiderBuy2,031$8.61$17,486.91View SEC Filing  
11/19/2013Henry JiCEOBuy2,000$8.59$17,180.00View SEC Filing  
11/19/2013Jaisim ShahDirectorBuy1,000$9.00$9,000.00View SEC Filing  
11/15/2013Opko Health, Inc.Major ShareholderSell2,710$8.75$23,712.50View SEC Filing  
11/14/2013Opko Health, Inc.Major ShareholderSell1,900$8.75$16,625.00View SEC Filing  
11/13/2013Opko Health, Inc.Major ShareholderSell13,457$8.75$117,748.75View SEC Filing  
11/8/2013Opko Health, Inc.Major ShareholderSell2,000$8.75$17,500.00View SEC Filing  
11/7/2013Opko Health, Inc.Major ShareholderSell120,380$9.03$1,087,031.40View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Sorrento Therapeutics (NASDAQ:SRNE)
DateHeadline
finance.yahoo.com logoSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Sorrento Therapeutics, Inc. for Potential … (NASDAQ:SRNE)
finance.yahoo.com - August 24 at 10:40 AM
4-traders.com logoPurcell Julie & Lefkowitz LLP Is Investigating Sorrento Therapeutics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors (NASDAQ:SRNE)
www.4-traders.com - August 23 at 7:42 PM
News IconSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Sorrento Therapeutics, Inc. for Potential Breaches Of Fiduc... (NASDAQ:SRNE)
ih.advfn.com - August 23 at 7:42 PM
News IconHow Analysts & Retail Investors Perceive Sorrento Therapeutics, Inc. (NASDAQ:SRNE) Shares - Post News (NASDAQ:SRNE)
www.kentuckypostnews.com - August 23 at 12:06 PM
prnewswire.com logoSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Sorrento Therapeutics, Inc. for Potential ... - PR Newswire (press release) (NASDAQ:SRNE)
www.prnewswire.com - August 23 at 12:06 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Sorrento Therapeutics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors (NASDAQ:SRNE)
finance.yahoo.com - August 23 at 12:06 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of Sorrento Therapeutics, Inc. - SRNE (NASDAQ:SRNE)
finance.yahoo.com - August 23 at 12:06 PM
investornewswire.com logoSorrento Therapeutics, Inc. (NASDAQ:SRNE) Reports Sales Of $0.902, Surprising Estimates By -18.371% - Investor Newswire (NASDAQ:SRNE)
www.investornewswire.com - August 22 at 7:28 PM
live-pr.com logoSorrento Therapeutics, Inc. (SRNE) - Financial and Strategic SWOT Analysis Review - New Study Released (NASDAQ:SRNE)
www.live-pr.com - August 18 at 10:37 AM
realistinvestor.com logoAnalysts See Sorrento Therapeutics, Inc. (NASDAQ:SRNE) Reporting EPS Of $-0.15 - RealistInvestor.com (NASDAQ:SRNE)
www.realistinvestor.com - August 17 at 7:53 PM
kcregister.com logoStock Runners: AxoGen, Inc. (NASDAQ:AXGN), Sorrento Therapeutics, Inc. (NASDAQ:SRNE), The Boeing Company ... - KC Register (NASDAQ:SRNE)
www.kcregister.com - August 16 at 7:39 PM
finance.yahoo.com logoSORRENTO THERAPEUTICS, INC. Financials (NASDAQ:SRNE)
finance.yahoo.com - August 16 at 7:39 PM
wsj.com logo[$$] Sorrento Subsidiary Acquires Semnur for Up to $200M (NASDAQ:SRNE)
www.wsj.com - August 16 at 7:39 PM
investornewswire.com logoAnalysts See Sales Of $145.571 For Sorrento Therapeutics, Inc. (NASDAQ:SRNE) - Investor Newswire (NASDAQ:SRNE)
www.investornewswire.com - August 16 at 10:51 AM
streetinsider.com logoSorrento Therapeutics (SRNE) Unit to Acquire Semnur Pharmaceuticals - StreetInsider.com (NASDAQ:SRNE)
www.streetinsider.com - August 16 at 10:51 AM
4-traders.com logoSORRENTO THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K) (NASDAQ:SRNE)
www.4-traders.com - August 15 at 7:55 PM
News IconFormer Celgene Chief Exec Joins Sorrento as Chief Medical Officer and President of Clinical Development (NASDAQ:SRNE)
www.biospace.com - August 15 at 7:55 PM
publicnow.com logoScintilla Pharmaceuticals, Inc., a Subsidiary of Sorrento Therapeutics, Inc., to Acquire Semnur Pharmaceuticals, Inc. to Further Deepen its Pain Management Pipeline (NASDAQ:SRNE)
www.publicnow.com - August 15 at 7:55 PM
finance.yahoo.com logoDr. Jerome Zeldis, M.D., Ph.D., former Chief Medical Officer of Celgene, to Join Sorrento as Chief Medical … (NASDAQ:SRNE)
finance.yahoo.com - August 15 at 9:43 AM
finance.yahoo.com logoDr. Jerome Zeldis, M.D., Ph.D., former Chief Medical Officer of Celgene, to Join Sorrento as Chief Medical Officer and President of Clinical Development (NASDAQ:SRNE)
finance.yahoo.com - August 15 at 9:43 AM
investornewswire.com logoSorrento Therapeutics, Inc. (NASDAQ:SRNE) Records An Estimated Annual Sales Mean Of $145.571 - Investor Newswire (NASDAQ:SRNE)
www.investornewswire.com - August 9 at 10:52 AM
streetinsider.com logoSorrento Therapeutics (SRNE) Unit Agrees to Acquire SCILEX Pharmaceuticals - StreetInsider.com (NASDAQ:SRNE)
www.streetinsider.com - August 9 at 10:52 AM
finance.yahoo.com logoMedovex Corp. Completes Financing Led by Sorrento Therapeutics, Inc. (NASDAQ:SRNE)
finance.yahoo.com - August 9 at 10:52 AM
streetinsider.com logoSorrento Therapeutics (SRNE) Unit Agrees to Acquire SCILEX Pharmaceuticals (NASDAQ:SRNE)
www.streetinsider.com - August 8 at 11:53 AM
nasdaq.com logoNotable Wednesday Option Activity: SRNE, CELG, RDUS (NASDAQ:SRNE)
www.nasdaq.com - August 4 at 10:47 AM
streetinsider.com logoSorrento Therapeutics (SRNE) to Form Killer Cell Therapies Joint Venture - StreetInsider.com (NASDAQ:SRNE)
www.streetinsider.com - August 2 at 7:56 PM
streetinsider.com logoSorrento Therapeutics (SRNE) to Form Killer Cell Therapies Joint Venture (NASDAQ:SRNE)
www.streetinsider.com - August 2 at 12:12 PM
finance.yahoo.com logo9:05 am Sorrento Therapeutics to create a JV with CHA Biotech to develop & commercialize CAR modified cellular therapies (NASDAQ:SRNE)
finance.yahoo.com - August 2 at 12:12 PM
publicnow.com logoSorrento to Form Joint Venture with CHA Biotech to Develop and Commercialize Natural Killer Cell Therapies (NASDAQ:SRNE)
www.publicnow.com - August 2 at 12:12 PM
biz.yahoo.com logoSORRENTO THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E (NASDAQ:SRNE)
biz.yahoo.com - August 1 at 7:22 PM
publicnow.com logoSorrento Therapeutics Announces the Appointment of Dr. Yue Alexander Wu to its Board of Directors (NASDAQ:SRNE)
www.publicnow.com - August 1 at 7:11 AM
investornewswire.com logoExpected For Sorrento Therapeutics, Inc. (NASDAQ:SRNE) Sales Of $145.571 - Investor Newswire (NASDAQ:SRNE)
www.investornewswire.com - July 26 at 7:58 PM
kcregister.com logoSorrento Therapeutics, Inc. (NASDAQ:SRNE) increased 6.03%: Violin Memory, Inc. (NYSE:VMEM), Spirit AeroSystems ... - KC Register (NASDAQ:SRNE)
www.kcregister.com - July 25 at 11:57 AM
News IconChecking in on Stock Volatility for: Sorrento Therapeutics, Inc. (NASDAQ:SRNE) - Engelwood Daily (NASDAQ:SRNE)
www.engelwooddaily.com - July 23 at 11:22 AM
News IconSorrento Therapeutics Incorporated (NASDAQ:SRNE) Shorted Shares Decreased By 0.55% - Consumer Eagle (NASDAQ:SRNE)
www.consumereagle.com - July 23 at 11:22 AM
News IconSorrento Therapeutics, Inc. (NASDAQ:SRNE): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:SRNE)
www.engelwooddaily.com - July 23 at 11:22 AM
News IconStock Up Nicely This Week: Sorrento Therapeutics, Inc. (NASDAQ:SRNE) - TGP (NASDAQ:SRNE)
telanaganapress.com - July 23 at 11:22 AM
News IconInvestor News: Lawsuit filed against certain directors of Sorrento Therapeutics Inc (NASDAQ:SRNE) (NASDAQ:SRNE)
www.groundreport.com - July 21 at 7:53 PM
News IconAfter Today's Huge Increase, Is Sorrento Therapeutics Inc's Near ... - Consumer Eagle (NASDAQ:SRNE)
www.consumereagle.com - July 21 at 10:23 AM
News IconEquity Roundup: Stock Performance Focus on Sorrento Therapeutics, Inc. (NASDAQ:SRNE) - Press Telegraph (NASDAQ:SRNE)
presstelegraph.com - July 20 at 10:30 AM
News IconInvestor News: Lawsuit filed against certain directors of Sorrento Therapeutics Inc (NASDAQ:SRNE) - GroundReport (NASDAQ:SRNE)
www.groundreport.com - July 20 at 10:30 AM
news.cmlviz.com logoSorrento Therapeutics Inc Realized Volatility Hits Extreme Level - CML News (NASDAQ:SRNE)
news.cmlviz.com - July 20 at 10:30 AM
capitalcube.com logoSorrento Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : SRNE-US : July 20, 2016 (NASDAQ:SRNE)
www.capitalcube.com - July 20 at 8:22 AM
investornewswire.com logoSorrento Therapeutics, Inc. (NASDAQ:SRNE) Expected To Post Sales Of $145.571 - Investor Newswire (NASDAQ:SRNE)
www.investornewswire.com - July 19 at 8:33 AM
news.cmlviz.com logoOption Market: Sorrento Therapeutics Inc Risk Hits An Elevated Level - CML News (NASDAQ:SRNE)
news.cmlviz.com - July 18 at 12:01 PM
News IconSorrento Therapeutics Incorporated (NASDAQ:SRNE) Sellers Increased By 0.61% Their Shorts - Consumer Eagle (NASDAQ:SRNE)
www.consumereagle.com - July 18 at 12:01 PM
fiscalstandard.com logoNext Weeks Broker Price Targets For Sorrento Therapeutics, Inc. (SRNE) - Fiscal Standard (NASDAQ:SRNE)
www.fiscalstandard.com - July 18 at 12:01 PM
News IconShares Moving Down on the Week: Sorrento Therapeutics, Inc. (NASDAQ:SRNE) - Engelwood Daily (NASDAQ:SRNE)
www.engelwooddaily.com - July 17 at 11:35 AM
News IconShares Experiencing a Downtrend: Sorrento Therapeutics, Inc. (NASDAQ:SRNE) - TGP (NASDAQ:SRNE)
telanaganapress.com - July 17 at 11:35 AM
News IconSorrento Therapeutics, Inc. (NASDAQ:SRNE) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:SRNE)
www.engelwooddaily.com - July 15 at 12:49 PM

Social

Sorrento Therapeutics (NASDAQ:SRNE) Chart for Tuesday, August, 30, 2016


Last Updated on 8/30/2016 by MarketBeat.com Staff